GRAFAPEX J Code: J0614

Drug & Product Overview

HCPCS Descriptor Injection, treosulfan, 50 mg

HCPCS Added Date October 1, 2025

Manufacturer Medexus Pharma

Route of Administration Intravenous

Generic Status Single-Source; Branded

Dosage Form Injection, Powder, Lyophilized, For Solution

About GRAFAPEX

Grafapex is a medication aligned to the HCPCS J Code: J0614 for billing, pricing, and reimbursement purposes in the United States. Classified under Oncology, it is administered via the intravenous route and manufactured by Medexus Pharma.

Manufacturers, reach out to us to add more information.

NDC Code Information

Based on publicly available CMS files. Showing 2 of 4 NDCs — log in for the full crosswalk.

NDC Code	Drug	Manufacturer	Billing Units / Pkg	Package Size
59137-0335-01	Grafapex	Medexus Pharma, Inc.	20	1000 MG
59137-0365-01	Grafapex	Medexus Pharma, Inc.	100	5000 MG
•••••-••••-•• Log in to view	GRAFAPEX
	GRAFAPEX

Login to view 2 more NDC packages View pricing, complete NDC-to-HCPCS alignments, and package details.

Login →

GRAFAPEX Pricing & Reimbursement

J0614 Private Payer Reimbursement

$32.32 / HCPCS unit as of Jan 2026

National median reimbursement across major commercial payers.

Create an account on PayerPrice for more information →

Historical Graphing and Billing Calculator

per HCPCS unit

As of Q3 2026

GRAFAPEX CPT Administration Codes

CPT Code	Description
96413	Chemotherapy administration, intravenous infusion technique; up to 1 hour, single or initial substance/drug
96415	Chemotherapy administration, intravenous infusion technique; each additional hour (List separately in addition to code for primary procedure)

Not on the CMS JW / JZ list

This product is new and does not yet appear on the CMS list of HCPCS pertaining to single-dose containers. Wastage billing guide →

GRAFAPEX Medically Unlikely Edits (MUE)

The most billing units of J0614 Medicare will pay for one patient in one day, as published by CMS. 1 unit = 50 mg.

Practitioner Office & Hospital Outpatient

600 units / day

= 30,000 mg per day

MAI 3 · Date of Service Edit: Clinical. Per-day limit based on clinical expectations; excess units are denied but may be appealed with documentation of medical necessity. See all MUE limits →

GRAFAPEX Clinical Information

Indications and drug classification.

Treated Diseases & Conditions

This list of indications is not exhaustive and may be subject to errors. The information on BuyandBill.com is intended for informational purposes only and should not be used for medical advice.

Acute Myeloid Leukemia Myelodysplastic Syndrome

Frequently Asked Questions

Is there an available Grafapex billing and coding guide?

Billing and coding information for GRAFAPEX can be found through Medexus Pharma, Inc.. Visit Here →

Are there any available Grafapex patient assistance programs?

GRAFAPEX patient assistance information can be found through Medexus Pharma, Inc.. Visit Here →

Where can I find Grafapex prescribing information?

Grafapex prescribing information can be found through the link below. Visit Here →

Where can I find Grafapex side effect information?

Grafapex side effect information can be found at the link below. Visit Here →

Does billing Grafapex require wastage modifiers?

CMS does not include GRAFAPEX (J0614) on its list of HCPCS pertaining to single-dose containers. Per CMS guidelines, the JZ/JW wastage modifiers may not apply when billing J0614. For more information, visit the link below.

About BuyandBill.com:

The BuyandBill.com team is dedicated to delivering high-quality coding and billing information for office-administered drugs. We continuously research HCPCS-coded medications to expand our resources and ensure data accuracy. Manufacturers: click here to sponsor your medication, and we will ensure the most accurate and detailed information is displayed.